Igelösa Life Science

Igelösa Life Science is a privately held Swedish medical research and innovation company based near Lund that conducts preclinical research, surgeon education, and commercialization support in transplantation, cardiopulmonary resuscitation, and preventive medicine. Founded in 1998 by Professor Stig Steen and entrepreneur Nils Gyllenkrok, the company has been associated with several notable translational innovations, including work underlying the LUCAS mechanical CPR system, ex vivo lung perfusion, and non-ischemic heart preservation. Its model appears to center on developing and validating medical technologies in close collaboration with Lund University and selected commercial partners rather than advancing a traditional drug pipeline. The company highlights research, training, and innovation activities aimed at bringing complex medical procedures and enabling technologies into clinical practice.